$NBS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CALADRIUS BIOSCIENCES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CALADRIUS BIOSCIENCES, INC.. Get notifications about new insider transactions in CALADRIUS BIOSCIENCES, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 15 2021 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Payment of Exercise | F | 1.56 | 5,936 | 9,260 | 299,505 | 305.4 K to 299.5 K (-1.94 %) |
Jan 15 2021 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Payment of Exercise | F | 1.55 | 6,425 | 9,959 | 305,441 | 311.9 K to 305.4 K (-2.06 %) |
Jan 15 2021 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Payment of Exercise | F | 1.55 | 21,787 | 33,770 | 311,866 | 333.7 K to 311.9 K (-6.53 %) |
Jan 15 2021 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Grant | A | 0.00 | 39,000 | 0 | 333,653 | 294.7 K to 333.7 K (+13.24 %) |
Jan 12 2021 | NBS | CALADRIUS BIOSCIEN ... | Whitaker Anne Clem | Director | Grant | A | 0.00 | 37,735 | 0 | 117,205 | 79.5 K to 117.2 K (+47.48 %) |
Jan 12 2021 | NBS | CALADRIUS BIOSCIEN ... | TRABER PETER G | Director | Grant | A | 0.00 | 37,735 | 0 | 83,760 | 46 K to 83.8 K (+81.99 %) |
Jan 12 2021 | NBS | CALADRIUS BIOSCIEN ... | Schwalm Cynthia | Director | Grant | A | 0.00 | 37,735 | 0 | 80,417 | 42.7 K to 80.4 K (+88.41 %) |
Jan 12 2021 | NBS | CALADRIUS BIOSCIEN ... | MYERS STEVEN S | Director | Grant | A | 0.00 | 37,735 | 0 | 113,054 | 75.3 K to 113.1 K (+50.10 %) |
Jan 12 2021 | NBS | CALADRIUS BIOSCIEN ... | KLOSK STEVEN M | Director | Grant | A | 0.00 | 37,735 | 0 | 85,960 | 48.2 K to 86 K (+78.25 %) |
Jan 12 2021 | NBS | CALADRIUS BIOSCIEN ... | Davidson Michael H. | Director | Grant | A | 0.00 | 37,735 | 0 | 144,323 | 106.6 K to 144.3 K (+35.40 %) |
Jan 12 2021 | NBS | CALADRIUS BIOSCIEN ... | BROWN GREGORY B | Director | Grant | A | 0.00 | 37,735 | 0 | 83,610 | 45.9 K to 83.6 K (+82.26 %) |
Jan 12 2021 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Option Exercise | A | 1.59 | 60,000 | 95,400 | 60,000 | |
Jan 12 2021 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Payment of Exercise | F | 1.59 | 16,621 | 26,427 | 294,653 | 311.3 K to 294.7 K (-5.34 %) |
Jan 12 2021 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Grant | A | 0.00 | 119,000 | 0 | 311,274 | 192.3 K to 311.3 K (+61.89 %) |
Jan 12 2021 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Payment of Exercise | F | 1.60 | 4,726 | 7,562 | 192,274 | 197 K to 192.3 K (-2.40 %) |
Nov 03 2020 | NBS | CALADRIUS BIOSCIEN ... | Whitaker Anne Clem | Director | Grant | A | 1.51 | 79,470 | 120,000 | 79,470 | 0 to 79.5 K |
Sep 10 2020 | NBS | CALADRIUS BIOSCIEN ... | Davidson Michael H. | Director | Buy | P | 1.80 | 55,525 | 99,945 | 106,588 | 51.1 K to 106.6 K (+108.74 %) |
Aug 12 2020 | NBS | CALADRIUS BIOSCIEN ... | Davidson Michael H. | Director | Grant | A | 2.35 | 51,063 | 119,998 | 51,063 | 0 to 51.1 K |
Jan 15 2020 | NBS | CALADRIUS BIOSCIEN ... | Talamo Joseph | SVP and CFO | Option Exercise | A | 3.28 | 29,000 | 95,120 | 29,000 | |
Jan 15 2020 | NBS | CALADRIUS BIOSCIEN ... | Talamo Joseph | SVP and CFO | Payment of Exercise | F | 3.38 | 2,190 | 7,402 | 59,644 | 61.8 K to 59.6 K (-3.54 %) |
Jan 15 2020 | NBS | CALADRIUS BIOSCIEN ... | Talamo Joseph | SVP and CFO | Payment of Exercise | F | 3.28 | 2,601 | 8,531 | 61,834 | 64.4 K to 61.8 K (-4.04 %) |
Jan 15 2020 | NBS | CALADRIUS BIOSCIEN ... | Talamo Joseph | SVP and CFO | Grant | A | 0.00 | 19,000 | 0 | 64,435 | 45.4 K to 64.4 K (+41.82 %) |
Jan 15 2020 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Option Exercise | A | 3.28 | 69,000 | 226,320 | 69,000 | |
Jan 15 2020 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Payment of Exercise | F | 3.38 | 6,382 | 21,571 | 186,382 | 192.8 K to 186.4 K (-3.31 %) |
Jan 15 2020 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Payment of Exercise | F | 3.28 | 6,246 | 20,487 | 192,764 | 199 K to 192.8 K (-3.14 %) |
Jan 15 2020 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Grant | A | 0.00 | 46,000 | 0 | 199,010 | 153 K to 199 K (+30.06 %) |
Jan 15 2020 | NBS | CALADRIUS BIOSCIEN ... | LOSORDO DOUGLAS W | See Remarks | Option Exercise | A | 3.28 | 29,000 | 95,120 | 29,000 | |
Jan 15 2020 | NBS | CALADRIUS BIOSCIEN ... | LOSORDO DOUGLAS W | See Remarks | Payment of Exercise | F | 3.38 | 2,190 | 7,402 | 130,406 | 132.6 K to 130.4 K (-1.65 %) |
Jan 15 2020 | NBS | CALADRIUS BIOSCIEN ... | LOSORDO DOUGLAS W | See Remarks | Payment of Exercise | F | 3.28 | 2,601 | 8,531 | 132,596 | 135.2 K to 132.6 K (-1.92 %) |
Jan 15 2020 | NBS | CALADRIUS BIOSCIEN ... | LOSORDO DOUGLAS W | See Remarks | Grant | A | 0.00 | 19,000 | 0 | 135,197 | 116.2 K to 135.2 K (+16.35 %) |
Jan 14 2020 | NBS | CALADRIUS BIOSCIEN ... | TRABER PETER G | Director | Grant | A | 3.28 | 18,292 | 59,998 | 46,025 | 27.7 K to 46 K (+65.96 %) |
Jan 14 2020 | NBS | CALADRIUS BIOSCIEN ... | Schwalm Cynthia | Director | Grant | A | 3.28 | 18,292 | 59,998 | 42,682 | 24.4 K to 42.7 K (+75.00 %) |
Jan 14 2020 | NBS | CALADRIUS BIOSCIEN ... | MYERS STEVEN S | Director | Grant | A | 3.28 | 18,292 | 59,998 | 75,319 | 57 K to 75.3 K (+32.08 %) |
Jan 14 2020 | NBS | CALADRIUS BIOSCIEN ... | KLOSK STEVEN M | Director | Grant | A | 3.28 | 18,292 | 59,998 | 48,225 | 29.9 K to 48.2 K (+61.11 %) |
Jan 14 2020 | NBS | CALADRIUS BIOSCIEN ... | BROWN GREGORY B | Director | Grant | A | 3.28 | 18,292 | 59,998 | 45,875 | 27.6 K to 45.9 K (+66.32 %) |
Jan 09 2020 | NBS | CALADRIUS BIOSCIEN ... | Talamo Joseph | SVP and CFO | Payment of Exercise | F | 2.83 | 1,821 | 5,153 | 45,435 | 47.3 K to 45.4 K (-3.85 %) |
Jan 09 2020 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Payment of Exercise | F | 2.83 | 4,522 | 12,797 | 153,010 | 157.5 K to 153 K (-2.87 %) |
Jan 09 2020 | NBS | CALADRIUS BIOSCIEN ... | LOSORDO DOUGLAS W | See Remarks | Payment of Exercise | F | 2.83 | 1,821 | 5,153 | 116,197 | 118 K to 116.2 K (-1.54 %) |
Jan 16 2019 | NBS | CALADRIUS BIOSCIEN ... | Talamo Joseph | SVP and CFO | Option Exercise | A | 4.95 | 24,000 | 118,800 | 24,000 | |
Jan 16 2019 | NBS | CALADRIUS BIOSCIEN ... | Talamo Joseph | SVP and CFO | Payment of Exercise | F | 0.00 | 2,159 | 0 | 47,256 | 49.4 K to 47.3 K (-4.37 %) |
Jan 16 2019 | NBS | CALADRIUS BIOSCIEN ... | Talamo Joseph | SVP and CFO | Grant | A | 0.00 | 16,000 | 0 | 49,415 | 33.4 K to 49.4 K (+47.88 %) |
Jan 16 2019 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Option Exercise | A | 4.95 | 71,000 | 351,450 | 71,000 | |
Jan 16 2019 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Payment of Exercise | F | 0.00 | 6,301 | 0 | 151,405 | 157.7 K to 151.4 K (-4.00 %) |
Jan 16 2019 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Grant | A | 0.00 | 47,000 | 0 | 157,706 | 110.7 K to 157.7 K (+42.45 %) |
Jan 16 2019 | NBS | CALADRIUS BIOSCIEN ... | LOSORDO DOUGLAS W | See Remarks | Option Exercise | A | 4.95 | 24,000 | 118,800 | 24,000 | |
Jan 16 2019 | NBS | CALADRIUS BIOSCIEN ... | LOSORDO DOUGLAS W | See Remarks | Payment of Exercise | F | 0.00 | 2,159 | 0 | 111,594 | 113.8 K to 111.6 K (-1.90 %) |
Jan 16 2019 | NBS | CALADRIUS BIOSCIEN ... | LOSORDO DOUGLAS W | See Remarks | Grant | A | 0.00 | 16,000 | 0 | 113,753 | 97.8 K to 113.8 K (+16.37 %) |
Jan 16 2019 | NBS | CALADRIUS BIOSCIEN ... | TRABER PETER G | Director | Grant | A | 4.95 | 12,121 | 59,999 | 27,733 | 15.6 K to 27.7 K (+77.64 %) |
Jan 16 2019 | NBS | CALADRIUS BIOSCIEN ... | Schwalm Cynthia | Director | Grant | A | 4.95 | 12,121 | 59,999 | 24,390 | 12.3 K to 24.4 K (+98.79 %) |
Jan 16 2019 | NBS | CALADRIUS BIOSCIEN ... | MYERS STEVEN S | Director | Grant | A | 4.95 | 12,121 | 59,999 | 57,027 | 44.9 K to 57 K (+26.99 %) |
Jan 16 2019 | NBS | CALADRIUS BIOSCIEN ... | KLOSK STEVEN M | Director | Grant | A | 4.95 | 12,121 | 59,999 | 29,933 | 17.8 K to 29.9 K (+68.05 %) |
Jan 16 2019 | NBS | CALADRIUS BIOSCIEN ... | BROWN GREGORY B | Director | Grant | A | 4.95 | 12,121 | 59,999 | 27,583 | 15.5 K to 27.6 K (+78.39 %) |
Jan 10 2019 | NBS | CALADRIUS BIOSCIEN ... | Talamo Joseph | SVP and CFO | Payment of Exercise | F | 4.64 | 1,795 | 8,329 | 33,415 | 35.2 K to 33.4 K (-5.10 %) |
Jan 10 2019 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Payment of Exercise | F | 4.64 | 4,478 | 20,778 | 110,706 | 115.2 K to 110.7 K (-3.89 %) |
Jan 10 2019 | NBS | CALADRIUS BIOSCIEN ... | LOSORDO DOUGLAS W | See Remarks | Payment of Exercise | F | 4.64 | 1,795 | 8,329 | 97,753 | 99.5 K to 97.8 K (-1.80 %) |
Jan 10 2019 | NBS | CALADRIUS BIOSCIEN ... | TRABER PETER G | Director | Grant | A | 0.00 | 8,747 | 0 | 15,612 | 6.9 K to 15.6 K (+127.41 %) |
Jan 10 2019 | NBS | CALADRIUS BIOSCIEN ... | MYERS STEVEN S | Director | Grant | A | 0.00 | 8,747 | 0 | 44,906 | 36.2 K to 44.9 K (+24.19 %) |
Jan 10 2019 | NBS | CALADRIUS BIOSCIEN ... | KLOSK STEVEN M | Director | Grant | A | 0.00 | 8,747 | 0 | 17,812 | 9.1 K to 17.8 K (+96.49 %) |
Jan 10 2019 | NBS | CALADRIUS BIOSCIEN ... | BROWN GREGORY B | Director | Grant | A | 0.00 | 8,747 | 0 | 15,462 | 6.7 K to 15.5 K (+130.26 %) |
Jun 21 2018 | NBS | CALADRIUS BIOSCIEN ... | Talamo Joseph | SVP and CFO | Payment of Exercise | F | 8.64 | 6,407 | 55,356 | 35,210 | 41.6 K to 35.2 K (-15.40 %) |
Jun 21 2018 | NBS | CALADRIUS BIOSCIEN ... | Talamo Joseph | SVP and CFO | Grant | A | 8.64 | 13,300 | 114,912 | 41,617 | 28.3 K to 41.6 K (+46.97 %) |
Jun 21 2018 | NBS | CALADRIUS BIOSCIEN ... | LOSORDO DOUGLAS W | See Remarks | Payment of Exercise | F | 8.64 | 6,407 | 55,356 | 93,982 | 100.4 K to 94 K (-6.38 %) |
Jun 21 2018 | NBS | CALADRIUS BIOSCIEN ... | LOSORDO DOUGLAS W | See Remarks | Grant | A | 8.64 | 13,300 | 114,912 | 100,389 | 87.1 K to 100.4 K (+15.27 %) |
Jun 21 2018 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Payment of Exercise | F | 8.64 | 16,091 | 139,026 | 109,453 | 125.5 K to 109.5 K (-12.82 %) |
Jun 21 2018 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Grant | A | 8.64 | 33,300 | 287,712 | 125,544 | 92.2 K to 125.5 K (+36.10 %) |
Apr 10 2018 | NBS | CALADRIUS BIOSCIEN ... | LOSORDO DOUGLAS W | See Remarks | Option Exercise | A | 0.00 | 13,300 | 0 | 13,300 | |
Apr 10 2018 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Option Exercise | A | 0.00 | 33,300 | 0 | 33,300 | |
Apr 10 2018 | NBS | CALADRIUS BIOSCIEN ... | Talamo Joseph | SVP and CFO | Option Exercise | A | 0.00 | 13,300 | 0 | 13,300 | |
Apr 10 2018 | NBS | CALADRIUS BIOSCIEN ... | LOSORDO DOUGLAS W | See Remarks | Option Exercise | A | 0.00 | 13,300 | 0 | 13,300 | |
Apr 10 2018 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Option Exercise | A | 0.00 | 33,300 | 0 | 33,300 | |
Apr 10 2018 | NBS | CALADRIUS BIOSCIEN ... | Talamo Joseph | SVP and CFO | Option Exercise | A | 0.00 | 13,300 | 0 | 13,300 | |
Jan 10 2018 | NBS | CALADRIUS BIOSCIEN ... | LOSORDO DOUGLAS W | See Remarks | Option Exercise | A | 3.79 | 20,000 | 75,800 | 20,000 | |
Jan 10 2018 | NBS | CALADRIUS BIOSCIEN ... | LOSORDO DOUGLAS W | See Remarks | Payment of Exercise | F | 0.00 | 1,803 | 0 | 87,089 | 88.9 K to 87.1 K (-2.03 %) |
Jan 10 2018 | NBS | CALADRIUS BIOSCIEN ... | LOSORDO DOUGLAS W | See Remarks | Grant | A | 0.00 | 13,300 | 0 | 88,892 | 75.6 K to 88.9 K (+17.59 %) |
Jan 10 2018 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Option Exercise | A | 3.79 | 50,000 | 189,500 | 20,000 | |
Jan 10 2018 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Payment of Exercise | F | 0.00 | 4,462 | 0 | 92,244 | 96.7 K to 92.2 K (-4.61 %) |
Jan 10 2018 | NBS | CALADRIUS BIOSCIEN ... | Mazzo David J | Chief Executive Off ... | Grant | A | 0.00 | 33,300 | 0 | 96,706 | 63.4 K to 96.7 K (+52.52 %) |
Jan 10 2018 | NBS | CALADRIUS BIOSCIEN ... | Talamo Joseph | SVP and CFO | Option Exercise | A | 3.79 | 20,000 | 75,800 | 20,000 | |
Jan 10 2018 | NBS | CALADRIUS BIOSCIEN ... | Talamo Joseph | SVP and CFO | Payment of Exercise | F | 0.00 | 1,803 | 0 | 28,317 | 30.1 K to 28.3 K (-5.99 %) |
Jan 10 2018 | NBS | CALADRIUS BIOSCIEN ... | Talamo Joseph | SVP and CFO | Grant | A | 0.00 | 13,300 | 0 | 30,120 | 16.8 K to 30.1 K (+79.07 %) |
Jan 10 2018 | NBS | CALADRIUS BIOSCIEN ... | MYERS STEVEN S | Director | Option Exercise | A | 0.00 | 8,747 | 0 | 8,747 | |
Jan 10 2018 | NBS | CALADRIUS BIOSCIEN ... | KLOSK STEVEN M | Director | Option Exercise | A | 0.00 | 8,747 | 0 | 8,747 | |
Jan 10 2018 | NBS | CALADRIUS BIOSCIEN ... | BROWN GREGORY B | Director | Option Exercise | A | 0.00 | 8,747 | 0 | 8,747 | |
Jan 10 2018 | NBS | CALADRIUS BIOSCIEN ... | TRABER PETER G | Director | Option Exercise | A | 0.00 | 8,747 | 0 | 8,747 | |
Nov 01 2017 | NBS | CALADRIUS BIOSCIEN ... | LOSORDO DOUGLAS W | See Remarks | Grant | A | 0.00 | 49,182 | 0 | 68,876 | 19.7 K to 68.9 K (+249.73 %) |
May 22 2017 | NBS | Caladrius Bioscien ... | Mazzo David J | Chief Executive Off ... | Payment of Exercise | F | 5.13 | 17,778 | 91,201 | 56,551 | 74.3 K to 56.6 K (-23.92 %) |
May 22 2017 | NBS | Caladrius Bioscien ... | LOSORDO DOUGLAS W | See Remarks | Payment of Exercise | F | 5.13 | 6,248 | 32,052 | 19,694 | 25.9 K to 19.7 K (-24.08 %) |
May 22 2017 | NBS | Caladrius Bioscien ... | Talamo Joseph | SVP and CFO | Payment of Exercise | F | 5.13 | 5,982 | 30,688 | 15,619 | 21.6 K to 15.6 K (-27.69 %) |
May 22 2017 | NBS | Caladrius Bioscien ... | Preti Robert A | Payment of Exercise | F | 5.13 | 8,842 | 45,359 | 33,786 | 42.6 K to 33.8 K (-20.74 %) | |
May 18 2017 | NBS | Caladrius Bioscien ... | BROWN GREGORY B | Director | Grant | A | 0.00 | 2,565 | 0 | 6,715 | 4.2 K to 6.7 K (+61.81 %) |
May 18 2017 | NBS | Caladrius Bioscien ... | TRABER PETER G | Director | Grant | A | 0.00 | 2,565 | 0 | 6,865 | 4.3 K to 6.9 K (+59.65 %) |
May 18 2017 | NBS | Caladrius Bioscien ... | KLOSK STEVEN M | Director | Grant | A | 0.00 | 2,565 | 0 | 9,065 | 6.5 K to 9.1 K (+39.46 %) |
May 18 2017 | NBS | Caladrius Bioscien ... | MYERS STEVEN S | Director | Grant | A | 0.00 | 2,565 | 0 | 36,159 | 33.6 K to 36.2 K (+7.64 %) |
Apr 27 2017 | NBS | Caladrius Bioscien ... | Talamo Joseph | SVP and CFO | Payment of Exercise | F | 4.74 | 214 | 1,014 | 21,601 | 21.8 K to 21.6 K (-0.98 %) |
Apr 27 2017 | NBS | Caladrius Bioscien ... | LOSORDO DOUGLAS W | See Remarks | Payment of Exercise | F | 4.74 | 224 | 1,062 | 25,942 | 26.2 K to 25.9 K (-0.86 %) |
Apr 27 2017 | NBS | Caladrius Bioscien ... | Preti Robert A | See Remarks | Payment of Exercise | F | 4.74 | 247 | 1,171 | 42,628 | 42.9 K to 42.6 K (-0.58 %) |
Feb 08 2017 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Sell | S | 4.77 | 6,575 | 31,375 | 172,223 | 178.8 K to 172.2 K (-3.68 %) |
Feb 06 2017 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Sell | S | 4.75 | 500 | 2,375 | 178,798 | 179.3 K to 178.8 K (-0.28 %) |
Feb 06 2017 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Sell | S | 4.76 | 1,525 | 7,256 | 179,298 | 180.8 K to 179.3 K (-0.84 %) |
Feb 06 2017 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Sell | S | 4.75 | 1,400 | 6,651 | 180,823 | 182.2 K to 180.8 K (-0.77 %) |
Feb 06 2017 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Sell | S | 4.51 | 5,000 | 22,547 | 182,223 | 187.2 K to 182.2 K (-2.67 %) |
Jan 31 2017 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Option Exercise | A | 3.54 | 2,750 | 9,735 | 2,750 | |
Jan 31 2017 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Grant | A | 0.00 | 1,650 | 0 | 4,300 | 2.7 K to 4.3 K (+62.26 %) |
Jan 31 2017 | NBS | Caladrius Bioscien ... | TRABER PETER G | Director | Option Exercise | A | 3.54 | 2,750 | 9,735 | 2,750 | |
Jan 31 2017 | NBS | Caladrius Bioscien ... | TRABER PETER G | Director | Grant | A | 0.00 | 1,650 | 0 | 4,300 | 2.7 K to 4.3 K (+62.26 %) |
Jan 31 2017 | NBS | Caladrius Bioscien ... | MYERS STEVEN S | Director | Option Exercise | A | 3.54 | 2,750 | 9,735 | 2,750 | |
Jan 31 2017 | NBS | Caladrius Bioscien ... | MYERS STEVEN S | Director | Grant | A | 0.00 | 1,650 | 0 | 33,594 | 31.9 K to 33.6 K (+5.17 %) |
Jan 31 2017 | NBS | Caladrius Bioscien ... | KLOSK STEVEN M | Director | Option Exercise | A | 3.54 | 2,750 | 9,735 | 2,750 | |
Jan 31 2017 | NBS | Caladrius Bioscien ... | KLOSK STEVEN M | Director | Grant | A | 0.00 | 1,650 | 0 | 6,500 | 4.9 K to 6.5 K (+34.02 %) |
Jan 31 2017 | NBS | Caladrius Bioscien ... | BERMAN RICHARD J | Director | Option Exercise | A | 3.54 | 2,750 | 9,735 | 2,750 | |
Jan 31 2017 | NBS | Caladrius Bioscien ... | BERMAN RICHARD J | Director | Grant | A | 0.00 | 1,650 | 0 | 7,177 | 5.5 K to 7.2 K (+29.85 %) |
Jan 31 2017 | NBS | Caladrius Bioscien ... | BROWN GREGORY B | Director | Option Exercise | A | 3.54 | 2,750 | 9,735 | 2,750 | |
Jan 31 2017 | NBS | Caladrius Bioscien ... | BROWN GREGORY B | Director | Grant | A | 0.00 | 1,650 | 0 | 4,150 | 2.5 K to 4.2 K (+66.00 %) |
Jan 27 2017 | NBS | Caladrius Bioscien ... | Mazzo David J | Chief Executive Off ... | Payment of Exercise | F | 3.87 | 761 | 2,945 | 75,019 | 75.8 K to 75 K (-1.00 %) |
Jan 27 2017 | NBS | Caladrius Bioscien ... | Talamo Joseph | See Remarks | Payment of Exercise | F | 3.87 | 239 | 925 | 21,812 | 22.1 K to 21.8 K (-1.08 %) |
Jan 27 2017 | NBS | Caladrius Bioscien ... | Preti Robert A | See Remarks | Payment of Exercise | F | 3.87 | 272 | 1,053 | 42,870 | 43.1 K to 42.9 K (-0.63 %) |
Jan 27 2017 | NBS | Caladrius Bioscien ... | LOSORDO DOUGLAS W | See Remarks | Payment of Exercise | F | 3.87 | 249 | 964 | 26,164 | 26.4 K to 26.2 K (-0.94 %) |
Jan 11 2017 | NBS | Caladrius Bioscien ... | Mazzo David J | Chief Executive Off ... | Option Exercise | A | 3.54 | 50,000 | 177,000 | 50,000 | |
Jan 11 2017 | NBS | Caladrius Bioscien ... | Mazzo David J | Chief Executive Off ... | Payment of Exercise | F | 3.54 | 4,758 | 16,843 | 75,780 | 80.5 K to 75.8 K (-5.91 %) |
Jan 11 2017 | NBS | Caladrius Bioscien ... | Mazzo David J | Chief Executive Off ... | Grant | A | 0.00 | 33,300 | 0 | 80,538 | 47.2 K to 80.5 K (+70.49 %) |
Jan 11 2017 | NBS | Caladrius Bioscien ... | Talamo Joseph | SVP and CFO | Option Exercise | A | 3.54 | 20,000 | 70,800 | 20,000 | |
Jan 11 2017 | NBS | Caladrius Bioscien ... | Talamo Joseph | SVP and CFO | Payment of Exercise | F | 3.54 | 1,672 | 5,919 | 22,051 | 23.7 K to 22.1 K (-7.05 %) |
Jan 11 2017 | NBS | Caladrius Bioscien ... | Talamo Joseph | SVP and CFO | Grant | A | 0.00 | 13,300 | 0 | 23,723 | 10.4 K to 23.7 K (+127.60 %) |
Jan 11 2017 | NBS | Caladrius Bioscien ... | Preti Robert A | See Remarks | Option Exercise | A | 3.54 | 27,500 | 97,350 | 27,500 | |
Jan 11 2017 | NBS | Caladrius Bioscien ... | Preti Robert A | See Remarks | Payment of Exercise | F | 3.54 | 2,482 | 8,786 | 43,142 | 45.6 K to 43.1 K (-5.44 %) |
Jan 11 2017 | NBS | Caladrius Bioscien ... | Preti Robert A | See Remarks | Grant | A | 0.00 | 18,300 | 0 | 45,624 | 27.3 K to 45.6 K (+66.97 %) |
Jan 11 2017 | NBS | Caladrius Bioscien ... | LOSORDO DOUGLAS W | See Remarks | Option Exercise | A | 3.54 | 20,000 | 70,800 | 20,000 | |
Jan 11 2017 | NBS | Caladrius Bioscien ... | LOSORDO DOUGLAS W | See Remarks | Payment of Exercise | F | 3.54 | 1,738 | 6,153 | 26,413 | 28.2 K to 26.4 K (-6.17 %) |
Jan 11 2017 | NBS | Caladrius Bioscien ... | LOSORDO DOUGLAS W | See Remarks | Grant | A | 0.00 | 13,300 | 0 | 28,151 | 14.9 K to 28.2 K (+89.56 %) |
Nov 25 2016 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Sell | S | 4.20 | 500 | 2,100 | 1,964,228 | 2 M to 2 M (-0.03 %) |
Nov 10 2016 | NBS | Caladrius Bioscien ... | Talamo Joseph | SVP and CFO | Payment of Exercise | F | 4.12 | 176 | 725 | 10,423 | 10.6 K to 10.4 K (-1.66 %) |
Nov 10 2016 | NBS | Caladrius Bioscien ... | Preti Robert A | See Remarks | Payment of Exercise | F | 4.12 | 164 | 676 | 26,331 | 26.5 K to 26.3 K (-0.62 %) |
Nov 10 2016 | NBS | Caladrius Bioscien ... | Mazzo David J | Chief Executive Off ... | Payment of Exercise | F | 4.12 | 457 | 1,883 | 47,238 | 47.7 K to 47.2 K (-0.96 %) |
Nov 10 2016 | NBS | Caladrius Bioscien ... | LOSORDO DOUGLAS W | See Remarks | Payment of Exercise | F | 4.12 | 176 | 725 | 14,851 | 15 K to 14.9 K (-1.17 %) |
Oct 12 2016 | NBS | Caladrius Bioscien ... | BROWN GREGORY B | Director | Option Exercise | A | 4.66 | 4,150 | 19,339 | 4,150 | |
Oct 12 2016 | NBS | Caladrius Bioscien ... | BROWN GREGORY B | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
Sep 30 2016 | NBS | Caladrius Bioscien ... | Talamo Joseph | SVP and CFO | Option Exercise | A | 4.77 | 13,377 | 63,808 | 13,377 | |
Sep 30 2016 | NBS | Caladrius Bioscien ... | Preti Robert A | See Remarks | Option Exercise | A | 4.77 | 20,894 | 99,664 | 20,894 | |
Sep 30 2016 | NBS | Caladrius Bioscien ... | Mazzo David J | Chief Executive Off ... | Option Exercise | A | 4.77 | 50,919 | 242,884 | 50,919 | |
Sep 30 2016 | NBS | Caladrius Bioscien ... | LOSORDO DOUGLAS W | See Remarks | Option Exercise | A | 4.77 | 17,199 | 82,039 | 17,199 | |
Aug 12 2016 | NBS | Caladrius Bioscien ... | Mazzo David J | Chief Executive Off ... | Payment of Exercise | F | 5.40 | 457 | 2,468 | 47,695 | 48.2 K to 47.7 K (-0.95 %) |
Aug 12 2016 | NBS | Caladrius Bioscien ... | Talamo Joseph | SVP and CFO | Payment of Exercise | F | 5.40 | 176 | 950 | 10,599 | 10.8 K to 10.6 K (-1.63 %) |
Aug 12 2016 | NBS | Caladrius Bioscien ... | Preti Robert A | See Remarks | Payment of Exercise | F | 5.40 | 164 | 886 | 26,495 | 26.7 K to 26.5 K (-0.62 %) |
Aug 12 2016 | NBS | Caladrius Bioscien ... | LOSORDO DOUGLAS W | See Remarks | Payment of Exercise | F | 5.40 | 176 | 950 | 14,397 | 14.6 K to 14.4 K (-1.21 %) |
Aug 09 2016 | NBS | Caladrius Bioscien ... | LOSORDO DOUGLAS W | See Remarks | Grant | A | 0.00 | 1,000 | 0 | 15,399 | 14.4 K to 15.4 K (+6.94 %) |
Jul 05 2016 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Sell | S | 0.61 | 16,094 | 9,787 | 1,877,228 | 1.9 M to 1.9 M (-0.85 %) |
Jul 05 2016 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Sell | S | 0.60 | 71,406 | 42,986 | 1,893,322 | 2 M to 1.9 M (-3.63 %) |
Jul 05 2016 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Sell | S | 0.61 | 16,094 | 9,787 | 1,877,228 | 1.9 M to 1.9 M (-0.85 %) |
Jul 05 2016 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Sell | S | 0.60 | 71,406 | 42,986 | 1,893,322 | 2 M to 1.9 M (-3.63 %) |
Jul 05 2016 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Sell | S | 0.61 | 16,094 | 9,787 | 1,877,228 | 1.9 M to 1.9 M (-0.85 %) |